Hematology analyzers have revolutionised clinical diagnostics by automating the complete blood count (CBC) and cell differentiation processes. These instruments integrate advanced optical, electrical, ...

Ligufalimab targets CD47, enhancing macrophage-mediated cancer cell destruction, and avoids red blood cell clumping, improving safety and efficacy. Early trials show ligufalimab, combined with Vidaza ...

Takeda Pharmaceutical is expanding its prospects in hematology with a deal for rights to a drug advancing to pivotal testing in a type of blood cancer, giving the Japanese pharmaceutical giant an ...